BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND PWWP2A, Q8IYR3_HUMAN, Q96N64, MST101, MGC132770, KIAA1935, ENSG00000170234, 114825
16776 results:

  • 1. HHLA2 deficiency inhibits pancreatic cancer progression and THP-1 macrophage M2 polarization via EGFR/MAPK/ERK and mTOR/AKT pathway.
    Zhou S; Wang Z; Zhao D; Fu Y; Zhang S; Wang Z; Zou X
    World J Surg Oncol; 2024 May; 22(1):133. PubMed ID: 38762741
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Potential drug targets for tumors identified through Mendelian randomization analysis.
    Song N; Shi P; Cui K; Zeng L; Wang Z; Di W; Li J; Fan Y; Li Z; Zhang J; Su W; Wang H
    Sci Rep; 2024 May; 14(1):11370. PubMed ID: 38762700
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Topographic analysis of pancreatic cancer by TMA and digital spatial profiling reveals biological complexity with potential therapeutic implications.
    Bingham V; Harewood L; McQuaid S; Craig SG; Revolta JF; Kim CS; Srivastava S; Quezada-Marín J; Humphries MP; Salto-Tellez M
    Sci Rep; 2024 May; 14(1):11361. PubMed ID: 38762572
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. NEMO/NF-κB signaling functions as a double-edged sword in PanIN formation versus progression to pancreatic cancer.
    Tsesmelis M; Büttner UFG; Gerstenlauer M; Manfras U; Tsesmelis K; Du Z; Sperb N; Weissinger SE; Möller P; Barth TFE; Maier HJ; Chan LK; Wirth T
    Mol Cancer; 2024 May; 23(1):103. PubMed ID: 38755681
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The role of the size of affinity ligands in the detection and characterization of extracellular vesicles.
    Pham CV; Chowdhury R; Patel S; Melke H; Hou Y; Xu H; Jia L; Duan A; Duan W; Xiang D
    Biosens Bioelectron; 2024 Aug; 258():116381. PubMed ID: 38744116
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. MKLN1-AS promotes pancreatic cancer progression as a crucial downstream mediator of HIF-1α through miR-185-5p/TEAD1 pathway.
    Chen J; Li L; Feng Y; Zhao Y; Sun F; Zhou X; Yiqi D; Li Z; Kong F; Kong X
    Cell Biol Toxicol; 2024 May; 40(1):30. PubMed ID: 38740637
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Exploiting the ferroaddiction of pancreatic cancer cells using Fe-doped nanoparticles.
    Lomphithak T; Sae-Fung A; Sprio S; Tampieri A; Jitkaew S; Fadeel B
    Nanomedicine; 2024 Jan; 55():102714. PubMed ID: 38738528
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [A rare case of intraductal tumor of the pancreas in which an intraductal tubulopapillary neoplasm was mixed with a widely spreading gastric-type intraductal papillary-mucinous neoplasm].
    Wakabayashi T; Shirota Y; Takeda Y; Hodo Y; Ueda Y
    Nihon Shokakibyo Gakkai Zasshi; 2024; 121(5):415-424. PubMed ID: 38735750
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Vitamin Nutritional Status in Patients with pancreatic cancer: A Narrative Review.
    Azzini E; Furini T; Polito A; Scalfi L; Pinto A; Gasperi V; Savini I; On Behalf Of The Sinu Nutrition In Oncology Working Group
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732007
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Cytokine CCL9 Mediates Oncogenic KRAS-Induced pancreatic Acinar-to-Ductal Metaplasia by Promoting Reactive Oxygen Species and Metalloproteinases.
    Liou GY; Byrd CJ; Storz P; Messex JK
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731942
    [TBL] [Abstract] [Full Text] [Related]  

  • 11.
    Di-Iacovo N; Ferracchiato S; Pieroni S; Scopetti D; Castelli M; Piobbico D; Pierucci L; Gargaro M; Chiasserini D; Servillo G; Della-Fazia MA
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731819
    [No Abstract]    [Full Text] [Related]  

  • 12. Mutation of SIVA, a candidate metastasis gene identified from clonally related bilateral breast cancers, promotes breast cancer cell spread in vitro and in vivo.
    Vermehren-Schmaedick A; Peto M; Wagoner W; Chiotti KE; Ramsey E; Wang X; Rakshe S; Minnier J; Sears R; Spellman P; Luoh SW
    PLoS One; 2024; 19(5):e0302856. PubMed ID: 38722955
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Dysregulated BH4 metabolism facilitates immunosuppression in pancreatic cancer.
    Cronin SJF
    Cell Metab; 2024 May; 36(5):886-888. PubMed ID: 38718754
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Small protein blockers of human IL-6 receptor alpha inhibit proliferation and migration of cancer cells.
    Groza Y; Lacina L; Kuchař M; Rašková Kafková L; Zachová K; Janoušková O; Osička R; Černý J; Petroková H; Mierzwicka JM; Panova N; Kosztyu P; Sloupenská K; Malý J; Škarda J; Raška M; Smetana K; Malý P
    Cell Commun Signal; 2024 May; 22(1):261. PubMed ID: 38715108
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. AnnoSpat annotates cell types and quantifies cellular arrangements from spatial proteomics.
    Mongia A; Zohora FT; Burget NG; Zhou Y; Saunders DC; Wang YJ; Brissova M; Powers AC; Kaestner KH; Vahedi G; Naji A; Schwartz GW; Faryabi RB
    Nat Commun; 2024 May; 15(1):3744. PubMed ID: 38702321
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A blueprint for tumor-infiltrating B cells across human cancers.
    Ma J; Wu Y; Ma L; Yang X; Zhang T; Song G; Li T; Gao K; Shen X; Lin J; Chen Y; Liu X; Fu Y; Gu X; Chen Z; Jiang S; Rao D; Pan J; Zhang S; Zhou J; Huang C; Shi S; Fan J; Guo G; Zhang X; Gao Q
    Science; 2024 May; 384(6695):eadj4857. PubMed ID: 38696569
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Long non-coding RNA LOXL1-AS1: a potential biomarker and therapeutic target in human malignant tumors.
    Fu XP; Ji CY; Tang WQ; Yu TT; Luo L
    Clin Exp Med; 2024 May; 24(1):93. PubMed ID: 38693424
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. 3D genomic mapping reveals multifocality of human pancreatic precancers.
    Braxton AM; Kiemen AL; Grahn MP; Forjaz A; Parksong J; Mahesh Babu J; Lai J; Zheng L; Niknafs N; Jiang L; Cheng H; Song Q; Reichel R; Graham S; Damanakis AI; Fischer CG; Mou S; Metz C; Granger J; Liu XD; Bachmann N; Zhu Y; Liu Y; Almagro-Pérez C; Jiang AC; Yoo J; Kim B; Du S; Foster E; Hsu JY; Rivera PA; Chu LC; Liu F; Fishman EK; Yuille A; Roberts NJ; Thompson ED; Scharpf RB; Cornish TC; Jiao Y; Karchin R; Hruban RH; Wu PH; Wirtz D; Wood LD
    Nature; 2024 May; 629(8012):679-687. PubMed ID: 38693266
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Exosomal HSPB1, interacting with FUS protein, suppresses hypoxia-induced ferroptosis in pancreatic cancer by stabilizing Nrf2 mRNA and repressing P450.
    Zhang L; Yang L; Du K
    J Cell Mol Med; 2024 May; 28(9):e18209. PubMed ID: 38682349
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Promising Therapeutic Approach in pancreatic cancer: Metabolism-Related Genes.
    Choe S; Kwak W; Kim E; Shin S; Shin M; Koh HJ; Yoon H
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):137. PubMed ID: 38682209
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 839.